Soudan B, Tetaert D, Hennebicq S, Briand G, Zerimech F, Richet C, Demeyer D, Gagnon J, Petillot Y, Degand P
INSERM Unité 377, Biologie et Physiopathologie des Cellules Mucipares, Lille, France.
J Pept Res. 1998 May;51(5):346-54. doi: 10.1111/j.1399-3011.1998.tb01225.x.
The in vitro O-glycosylation reaction of the MUC5AC mucin motif peptide, TTSAPTTS (in one-letter code), was achieved with human gastric microsomal homogenates. The analyses using capillary electrophoresis online coupled with electrospray mass spectrometry and further Edman degradation of the purified products (obtained by capillary electrophoresis at preparative scale) allowed us to distinguish two components at close masses: the addition of a mass of 202 corresponded to an N-terminal elongation of the peptide TTSAPTTS with the dipeptide (TT) and the addition of a mass of 203 corresponded to an N-acetylgalactosamine O-linkage. Using different peptidase inhibitors, a dipeptidyl peptidase/transferase activity was further characterized. A thiol dependence and an inhibition by H-Gly-PheCHN2 (specific to cathepsin C activity) were found. Moreover, besides TTSAPTTS, other MUC5AC motif peptides (GTTPSPVP, TSAPTTS) were also dipeptide donors (GT and TS, respectively) and our results suggested the involvement of a single dipeptidyl peptidase/transferase activity. Finally, this latter activity modified the in vitro GalNAc incorporation rates when using our selected MUC5AC motif peptides. Our study therefore shows that caution must be taken to prevent peptidic substrate elongation while performing in vitro O-glycosylation with microsomal preparations as the enzyme source. In fact, the results of the N-acetylgalactosamine incorporation rates and thus the microsomal N-acetylgalactosamine transferase affinity can be misinterpreted if dipeptidyl peptidase/transferase activity is not inhibited by the thiol inhibitor E-64 or the cathepsin C inhibitor H-Gly-PheCHN2.
利用人胃微粒体匀浆实现了黏蛋白MUC5AC基序肽TTSAPTTS(单字母编码)的体外O-糖基化反应。采用毛细管电泳在线联用电喷雾质谱分析,并对纯化产物(通过制备规模的毛细管电泳获得)进行进一步的埃德曼降解,使我们能够区分两个质量相近的组分:质量增加202对应于肽TTSAPTTS与二肽(TT)的N端延伸,质量增加203对应于N-乙酰半乳糖胺O-连接。使用不同的肽酶抑制剂,进一步表征了二肽基肽酶/转移酶活性。发现其对巯基有依赖性,并受到H-Gly-PheCHN2(对组织蛋白酶C活性具有特异性)的抑制。此外,除了TTSAPTTS,其他MUC5AC基序肽(GTTPSPVP、TSAPTTS)也是二肽供体(分别为GT和TS),我们的结果表明存在单一的二肽基肽酶/转移酶活性。最后,当使用我们选择的MUC5AC基序肽时,后一种活性改变了体外N-乙酰半乳糖胺掺入率。因此,我们的研究表明,在以微粒体制剂作为酶源进行体外O-糖基化时,必须注意防止肽底物的延伸。事实上,如果二肽基肽酶/转移酶活性未被巯基抑制剂E-64或组织蛋白酶C抑制剂H-Gly-PheCHN2抑制,N-乙酰半乳糖胺掺入率的结果以及微粒体N-乙酰半乳糖胺转移酶亲和力可能会被误解。